Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of 2 Oral Doses, 25 mg Twice Daily and 100 mg Twice Daily, of PG-760564 in Adult Patients With RA Receiving Methotrexate

NCT00369928 is registered in ClinicalTrials.gov with Procter and Gamble as lead sponsor.

NCT NCT00369928
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00369928 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of 2 Oral Doses, 25 mg Twice Daily and 100 mg Twice Daily, of PG-760564 in Adult Patients With RA Receiving Methotrexate
Lead sponsor
Procter and Gamble
Phase
Phase 2
Overall status
Completed
Start date
August 31, 2006
Completion date
January 31, 2008
Enrollment
254 (actual)
Sites
53

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis